Concordance of PGT for aneuploidies between blastocyst biopsies and spent blastocyst culture medium

• Published in: Reproductive biomedicine online Vol. 46; no. 3; pp. 483 - 490
• Main Authors: Xu, Chang Long, Wei, Yong Quan, Tan, Qing Ying, Huang, Ying, Wu, Jing Jing, Li, Chun Yuan, Ma, Ya Feng, Zhou, Ling, Liang, Bo, Kong, Ling Yin, Xu, Rui Xia, Wang, Ying Ying
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Ltd 01.03.2023
• Subjects: Aneuploidy; Biopsy; Blastocyst - pathology; Blastocyst culture medium; Cell-free DNA; Cell-Free Nucleic Acids; Female; Genetic Testing - methods; Humans; Inner cell mass; Non-invasive PGT; Pregnancy; Preimplantation Diagnosis - methods; Reproducibility of Results; Residual blastocyst; Trophectoderm biopsy; Trophectoderm biopsy; Blastocyst culture medium; Cell-free DNA; Non-invasive PGT; Residual blastocyst; Inner cell mass
• ISSN: 1472-6483; 1472-6491
• DOI: 10.1016/j.rbmo.2022.10.001

Non-invasive preimplantation genetic testing for aneuploidies (niPGT-A) avoids the possible detrimental impact of invasive PGT-A on embryo development and clinical outcomes. Does cell-free DNA (cfDNA) from spent blastocyst culture medium (BCM) reflect embryonic chromosome status better than trophectoderm (TE) biopsy? In this study, 35 donated embryos were used for research and the BCM, TE biopsy, inner cell mass (ICM) and residual blastocyst (RB) were individually picked up from these embryos. Whole genome amplification (WGA) was performed and amplified DNA was subject to next-generation sequencing. Chromosome status concordance was compared among the groups of samples. The WGA success rates were 97.0% (TE biopsy), 100% (ICM), 97.0% (RB) and 88.6% (BCM). Using ICM as the gold standard, the chromosomal ploidy concordance rates for BCM, TE biopsy and RB were 58.33% (14/24), 68.75% (22/32) and 78.57% (22/28); the diagnostic concordance rates were 83.33% (20/24), 87.50% (28/32) and 92.86% (26/28); and the sex concordance rates were 92.31% (24/26), 100% (32/32) and 100% (28/28), respectively. Considering RB the gold standard, the chromosome ploidy concordance rates for BCM and TE biopsy were 61.90% (13/21) and 81.48% (22/27); the diagnostic concordance rates were 71.43% (15/21) and 88.89% (24/27); and the sex concordance rates were 91.30% (21/23) and 100% (27/27), respectively. The results of niPGT-A of cfDNA of spent BCM are comparable to those of invasive PGT-A of TE biopsies. Modifications of embryo culture conditions and testing methods will help reduce maternal DNA contamination and improve the reliability of niPGT-A.